|
ORC2L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.127200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.652400E-01 |
| Normal-vs-Stage2 |
4.485200E-01 |
| Normal-vs-Stage3 |
7.590400E-01 |
| Normal-vs-Stage4 |
5.537600E-01 |
| Stage1-vs-Stage2 |
2.157200E-01 |
| Stage1-vs-Stage3 |
8.925400E-01 |
| Stage1-vs-Stage4 |
3.409600E-01 |
| Stage2-vs-Stage3 |
3.771800E-01 |
| Stage2-vs-Stage4 |
9.928400E-01 |
| Stage3-vs-Stage4 |
4.473800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.521600E-01 |
| Normal-vs-AfricanAmerican |
5.279200E-01 |
| Normal-vs-Asian |
7.185600E-01 |
| Caucasian-vs-AfricanAmerican |
4.700600E-01 |
| Caucasian-vs-Asian |
8.330000E-01 |
| AfricanAmerican-vs-Asian |
9.641200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.599600E-01 |
| Normal-vs-Female |
3.176400E-02 |
| Male-vs-Female |
5.279800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.251600E-01 |
| Normal-vs-Extreme_Weight |
8.964100E-02 |
| Normal-vs-Obese |
4.867400E-01 |
| Normal-vs-Extreme_Obese |
8.660000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.200200E-01 |
| Normal_Weight-vs-Obese |
3.279400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.942200E-01 |
| Extreme_Weight-vs-Obese |
3.850100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.717600E-01 |
| Obese-vs-Extreme_Obese |
8.604400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.284400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.673170E-01 |
| Normal-vs-Age(61-80Yrs) |
3.483400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.402400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.743400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.289800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.828400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.662100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.540560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.325800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.055600E-01 |
| Normal-VS-Type2 PRCC |
1.201850E-01 |
| Normal-VS-KIRP CIMP |
6.025900E-02 |
| Normal-VS-Unclassified PRCC |
6.280400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.322100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.091900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.942800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.684600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.326600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.591990E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.448300E-02 |
| Normal-vs-N1 |
8.712400E-02 |
| Normal-vs-N2 |
8.799000E-01 |
| N0-vs-N1 |
1.279500E-02 |
| N0-vs-N2 |
3.619200E-01 |
| N1-vs-N2 |
5.085000E-01 |
|
|
